Relative risk † 3 months After SC | p | Relative risk † 6 months After SC | p | Relative risk † 12 months Post-OP | p | Relative risk † 24 months Post-OP | p | |
---|---|---|---|---|---|---|---|---|
Neoadjuvant CRT | – | – | – | – | 20.1 (2.7; 166.2) | 0.004 | 9.7 (1.7; 55.3) | 0.011 |
Non-performed pIONM | 7.2 (1.4; 38.4) | 0.021 | 5.6 (1.3; 24.0) | 0.021 | 27.3 (3.2; 232.4) | 0.002 | 11.0 (1.9; 63.4) | 0.007 |
Tumor in the lower rectal third | – | – | – | – | 25.5 (3.1; 207.4) | 0.002 | 10.8 (1.9; 62.5) | 0.008 |